JP2010526106A5 - - Google Patents

Download PDF

Info

Publication number
JP2010526106A5
JP2010526106A5 JP2010506709A JP2010506709A JP2010526106A5 JP 2010526106 A5 JP2010526106 A5 JP 2010526106A5 JP 2010506709 A JP2010506709 A JP 2010506709A JP 2010506709 A JP2010506709 A JP 2010506709A JP 2010526106 A5 JP2010526106 A5 JP 2010526106A5
Authority
JP
Japan
Prior art keywords
sulfonamido
dibenzo
furan
acid
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010506709A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010526106A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/062593 external-priority patent/WO2008137816A2/en
Publication of JP2010526106A publication Critical patent/JP2010526106A/ja
Publication of JP2010526106A5 publication Critical patent/JP2010526106A5/ja
Withdrawn legal-status Critical Current

Links

JP2010506709A 2007-05-04 2008-05-05 マトリックスメタロプロテアーゼインヒビターとしての三環式化合物 Withdrawn JP2010526106A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92756307P 2007-05-04 2007-05-04
PCT/US2008/062593 WO2008137816A2 (en) 2007-05-04 2008-05-05 Tricyclic compounds as matrix metalloproteinase inhibitors

Publications (2)

Publication Number Publication Date
JP2010526106A JP2010526106A (ja) 2010-07-29
JP2010526106A5 true JP2010526106A5 (OSRAM) 2012-05-17

Family

ID=39944224

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506709A Withdrawn JP2010526106A (ja) 2007-05-04 2008-05-05 マトリックスメタロプロテアーゼインヒビターとしての三環式化合物

Country Status (11)

Country Link
US (1) US20100227859A1 (OSRAM)
EP (1) EP2144893A2 (OSRAM)
JP (1) JP2010526106A (OSRAM)
AR (1) AR066412A1 (OSRAM)
CA (1) CA2685389A1 (OSRAM)
CL (1) CL2008001257A1 (OSRAM)
MX (1) MX2009011749A (OSRAM)
PA (1) PA8779101A1 (OSRAM)
PE (1) PE20090223A1 (OSRAM)
TW (1) TW200900397A (OSRAM)
WO (1) WO2008137816A2 (OSRAM)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE517106T1 (de) * 2006-02-22 2011-08-15 Vertex Pharma Kondensierte spiropiperidine als modulatoren muskarinartiger rezeptoren
US9273021B2 (en) 2009-02-05 2016-03-01 Trustees Of Boston College Dibenzofuran derivatives as inhibitors of fructose 1,6-bisphosphatase and methods of use thereof
WO2010117932A1 (en) * 2009-04-06 2010-10-14 Schering Corporation Indole derivatives and methods for antiviral treatment
CN104995559B (zh) 2013-02-08 2020-04-07 三菱瓦斯化学株式会社 抗蚀剂组合物、抗蚀图案形成方法和用于其的多元酚衍生物
CN105377851B (zh) * 2013-03-11 2018-07-20 密执安州立大学董事会 Bet布罗莫结构域抑制剂和使用这些抑制剂的治疗方法
EP2907512A1 (en) 2014-02-14 2015-08-19 Commissariat A L'energie Atomique Et Aux Energies Alternatives Inhibitors of MMP-12 as antiviral Agents
SG11201705038XA (en) 2014-12-25 2017-07-28 Mitsubishi Gas Chemical Co Compound, resin, material for forming underlayer film for lithography, underlayer film for lithography, pattern forming method, and purification method
US11256170B2 (en) 2015-03-31 2022-02-22 Mitsubishi Gas Chemical Company, Inc. Compound, resist composition, and method for forming resist pattern using it
WO2016158169A1 (ja) 2015-03-31 2016-10-06 三菱瓦斯化学株式会社 レジスト組成物、レジストパターン形成方法、及びそれに用いるポリフェノール化合物
EP3346335A4 (en) 2015-08-31 2019-06-26 Mitsubishi Gas Chemical Company, Inc. MATERIAL FOR FORMING LITHOGRAPHY OF LAYER LAYERS, COMPOSITION FOR FORMING LITHOGRAPHY LAYER LAYERS, LITHOGRAPHY LAYERINGS AND METHOD FOR THE PRODUCTION THEREOF, PATTERN FORMULATION, RESIN AND CLEANING METHOD
JP7020912B2 (ja) 2015-08-31 2022-02-16 三菱瓦斯化学株式会社 リソグラフィー用下層膜形成材料、リソグラフィー用下層膜形成用組成物、リソグラフィー用下層膜及びその製造方法、並びにレジストパターン形成方法
CN108137478B (zh) 2015-09-10 2021-09-28 三菱瓦斯化学株式会社 化合物、其组合物、纯化方法以及抗蚀图案形成方法、非晶膜的制造方法
US10042251B2 (en) 2016-09-30 2018-08-07 Rohm And Haas Electronic Materials Llc Zwitterionic photo-destroyable quenchers
GB201617339D0 (en) 2016-10-12 2016-11-23 Lytix Biopharma As Therapeutic compounds
KR102435507B1 (ko) * 2019-07-31 2022-08-24 일동제약(주) 신규 벤조퓨란 유도체 및 이의 용도
CN113929645B (zh) * 2021-12-15 2022-03-11 长沙普济生物科技股份有限公司 一种光催化合成苯并呋喃基氨基酸表面活性剂的方法
CN117045635A (zh) * 2022-05-13 2023-11-14 中国海洋大学 一种3-苯基二苯并呋喃类化合物在药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2256716A1 (en) * 1996-09-04 1998-03-12 Warner-Lambert Company Matrix metalloproteinase inhibitors and their therapeutic uses
KR20000068415A (ko) * 1996-09-04 2000-11-25 로즈 암스트롱, 크리스틴 에이. 트러트웨인 매트릭스 메탈로프로테이나제 억제용 화합물 및 방법
TR200202211T2 (tr) * 1999-08-18 2002-11-21 Warner-Lambert Company Matris metaloproteinaz inhibitörleri olarak kullanışlı olan hidroksamik asit bileşikleri
MXPA01013172A (es) * 2001-02-14 2002-08-21 Warner Lambert Co Inhibidores sulfonamida de metaloproteinasa de matriz.
US20030157110A1 (en) * 2002-01-07 2003-08-21 Millennium Pharmaceuticals, Inc. Methods for the treatment of metabolic disorders, including obesity and diabetes
CA2667644A1 (en) * 2006-10-27 2008-05-15 Wyeth Tricyclic compounds as matrix metalloproteinase inhibitors

Similar Documents

Publication Publication Date Title
JP2010526106A5 (OSRAM)
RU2013120064A (ru) Композиции и способы лечения глазного отека, неоваскуляризации и связанных с ними заболеваний
JP2007516173A5 (OSRAM)
JP2017538750A5 (OSRAM)
RU2491285C2 (ru) Органические соединения
RU2352568C2 (ru) [1,2,4]оксадиазолы (варианты), способ их получения, фармацевтическая композиция и способ ингибирования активации метаботропных глютаматных рецепторов-5
JP2006513258A5 (OSRAM)
JP2009525984A5 (OSRAM)
JP2010533158A5 (OSRAM)
RU2009109147A (ru) Органические соединения
CA2656915A1 (en) Human protein tyrosine phosphatase inhibitors and methods of use
RU2011133833A (ru) Способы лечения синдрома сосудистой утечки
JP2005526815A5 (OSRAM)
JP2010540462A5 (OSRAM)
JP2006502134A5 (OSRAM)
JP2008526866A5 (OSRAM)
JP2015509510A5 (OSRAM)
RU2017125520A (ru) Соединения, ингибирующие parg
RU2004127928A (ru) Производные морфолинилмочевины для использования в лечении воспалительных заболеваний
JP2010506825A5 (OSRAM)
JP2013514308A5 (OSRAM)
JP2007523905A5 (OSRAM)
JP2006503009A5 (OSRAM)
JP2009524677A5 (OSRAM)
JP2008503497A5 (OSRAM)